Literature DB >> 32555517

Glaucoma in large-scale population-based epidemiology: a questionnaire-based proxy.

Anna Neustaeter1,2,3, Jelle Vehof4, Harold Snieder2,3, Nomdo M Jansonius5,6.   

Abstract

PURPOSE: To improve upon self-reported glaucoma status in population-based cohorts by developing a questionnaire-based proxy incorporating self-reported status in conjunction with glaucoma-specific visual complaints.
METHODS: A vision specific questionnaire, including questions from the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25) was administered to 79,866 Lifelines participants, a population-based cohort study in the Northern Netherlands. We compared NEI-VFQ-25 responses between 'definite' glaucoma cases (n = 90; self-reported surgical cases) and an age- and gender-matched subset of controls (n = 1,800) to uncover glaucoma-specific visual complaints, using a case-control logistic regression. We defined 'probable glaucoma' as both self-reported disease status and visual complaints, and 'possible glaucoma' as either. To evaluate the resulting proxy, we determined age-stratified glaucoma prevalences in the remaining cohort and compared the result to the literature.
RESULTS: Per unit increase in the vision subscales (range 0-100) distance, peripheral and low luminance, we observed significantly increased odds of definite glaucoma (2% [P = 0.03], 4% [P = 1.2 × 10-8] and 2% [P = 0.02], respectively); the associated area under the curve was 0.73. We identified 300 probable and 3,015 (1,434 by self-report) possible glaucoma cases. Standardised prevalences of definite, probable and possible glaucoma for 55+ were 0.4%, 1.1% and 7.3%, respectively. For self-reported glaucoma (combining definite, probable and possible by self-report), this was 5.2%.
CONCLUSIONS: The combination of self-reported glaucoma status and visual complaints can be used to capture glaucoma cases in population-based settings. The resulting prevalence of combined definite and probable glaucoma (1.5%) appears to be more consistent with previous reports than the prevalence estimate of 5.2% based only on self-report.

Entities:  

Year:  2020        PMID: 32555517      PMCID: PMC8010090          DOI: 10.1038/s41433-020-0882-4

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total

1.  Changing views on open-angle glaucoma: definitions and prevalences--The Rotterdam Study.

Authors:  R C Wolfs; P H Borger; R S Ramrattan; C C Klaver; C A Hulsman; A Hofman; J R Vingerling; R A Hitchings; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

  1 in total
  4 in total

1.  Repurposing Antihypertensive Drugs for the Prevention of Glaucoma: A Mendelian Randomization Study.

Authors:  Jingjing Liu; Shuang Li; Yang Hu; Shizheng Qiu
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

2.  Evaluating machine learning classifiers for glaucoma referral decision support in primary care settings.

Authors:  Omkar G Kaskar; Elaine Wells-Gray; David Fleischman; Landon Grace
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

3.  Mitochondrial Genome Study Identifies Association Between Primary Open-Angle Glaucoma and Variants in MT-CYB, MT-ND4 Genes and Haplogroups.

Authors:  Valeria Lo Faro; Ilja M Nolte; Jacoline B Ten Brink; Harold Snieder; Nomdo M Jansonius; Arthur A Bergen
Journal:  Front Genet       Date:  2021-12-16       Impact factor: 4.599

4.  Autonomic Dysfunction and Blood Pressure in Glaucoma Patients: The Lifelines Cohort Study.

Authors:  Nigus G Asefa; Anna Neustaeter; Nomdo M Jansonius; Harold Snieder
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.